Decheng Capital’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-646,057
Closed -$213K 18
2025
Q4
$213K Hold
646,057
0.03% 18
2025
Q3
$115K Hold
646,057
0.02% 23
2025
Q2
$127K Hold
646,057
0.03% 25
2025
Q1
$44K Hold
646,057
0.01% 27
2024
Q4
$149K Hold
646,057
0.03% 28
2024
Q3
$63.2K Hold
646,057
0.02% 26
2024
Q2
$103K Buy
+646,057
New +$132K 0.03% 23

Decheng Capital's NUVB.WS Position: Q1 2026 in Review

Decheng Capital sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 646,057 shares — an estimated $213K sold.

Decheng Capital first reported a position in NUVB.WS in Q2 2024 and held it in 7 quarters. The position peaked at $213K in Q4 2025. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.

  • Decheng Capital reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
  • Decheng Capital sold 646,057 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $213K.
  • Decheng Capital first reported a position in Nuvation Bio Inc Warrants in Q2 2024 and held it in 7 quarters.
  • Decheng Capital's Nuvation Bio Inc Warrants position peaked at $213K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.

Based on Decheng Capital's 13F filing for Q1 2026, filed 13 May 2026.